Irvine, California
United States
54
2021-04-29
The entities that hold a legal rights for patent applications filed by inventor Malone Thomas C.:
Thomas C. Malone from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:
BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS
#2 | 2021-04-22PYRIDYL BENZOTHIOPHENES AS KINASE INHIBITORS
#3 | 2019-02-07Biodegradable intravitreal tyrosine kinase implants
#4 | 2018-04-26Pyridyl benzothiophenes as kinase inhibitors
#5 | 2018-04-19Pyridyl benzothiophenes as kinase inhibitors
#6 | 2018-02-08METHOD OF TREATING CONDITIONS WITH KINASE INHIBITORS
#7 | 2017-08-10Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
#8 | 2017-06-294-pregenen-11β-17-21-triol-3,20-dione derivatives
#9 | 2017-06-22Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
#10 | 2017-05-25Method of treating conditions with kinase inhibitors
#11 | 2017-04-20Pyridyl benzothiophenes as kinase inhibitors
#12 | 2017-04-06Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
#13 | 2016-07-14Biodegradable intravitreal tyrosine kinase implants
#14 | 2016-07-07Substituted nicotinamide derivatives as kinase inhibitors
#15 | 2016-04-14Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2
#16 | 2016-04-14Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
#17 | 2016-04-14Pyridyl benzothiophenes as kinase inhibitors
#18 | 2016-04-14Indole-3-carboxamides as kinase inhibitors
#19 | 2016-04-07Substituted 1,2,3,4-tetrahydropyrido[3,4-E] pyrrolo[1,2-A]pyrimidines as kinase
#20 | 2016-04-07Kinase inhibitors
#21 | 2016-04-07Indole-1-carboxamides as kinase inhibitors
#22 | 2016-02-09Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors
#23 | 2016-01-12Kinase inhibitors
#24 | 2015-04-09SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-INDOL-2-ONE'S AND DERIVATIVES THEREOF AS KINASE INHIBITORS
#25 | 2015-02-264-pregenen-11β-17-21-triol-3,20-dione derivatives
#26 | 2015-01-15Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
#27 | 2014-09-11Kinase inhibitors
#28 | 2014-01-30Biodegradable intravitreal tyrosine kinase implants
#29 | 2013-11-21Kinase inhibitors
#30 | 2013-10-10KINASE INHIBITORS
#31 | 2013-09-12Kinase inhibitors
#32 | 2013-09-12Method of treating conditiions with kinase inhibitors
#33 | 2013-08-22Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
#34 | 2013-08-15Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
#35 | 2013-07-043-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors
#36 | 2013-05-16Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
#37 | 2013-05-164-pregenen-11β-17-21-triol-3,20-dione derivatives
#38 | 2012-09-20Kinase inhibitors
#39 | 2012-08-16Kinase Inhibitors
#40 | 2011-10-27Kinase inhibitors
#41 | 2011-10-20Heteroaryl dihydroindolones as kinase inhibitors
#42 | 2009-11-19Kinase inhibitors
#43 | 2009-08-20Kinase inhibitors
#44 | 2009-08-06Kinase inhibitors
#45 | 2009-04-16Sulfoximines as kinase inhibitors
#46 | 2008-10-23Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
#47 | 2008-10-16Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
#48 | 2008-02-21Heteroaryl dihydroindolones as kinase inhibitors
#49 | 2007-07-26Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
#50 | 2007-07-26Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
#51 | 2007-03-15Anti-angiogenic sustained release intraocular implants and related methods
#52 | 2005-11-03Biodegradable intravitreal tyrosine kinase implants
#53 | 2005-11-03Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
#54 | 2005-02-17Process for preparing isomerically pure prodrugs of proton pump inhibitors
249100 ⎘